{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:48:46Z","timestamp":1787500126539,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.clbc.2019.05.015","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T02:25:42Z","timestamp":1559787942000},"page":"e82-e88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Do Decreased Breast Microcalcifications After Neoadjuvant Chemotherapy Predict Pathologic Complete Response?"],"prefix":"10.1016","volume":"20","author":[{"given":"Atsushi","family":"Fushimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2019.05.015_bib1","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.2007.15.3510","article-title":"Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease","volume":"26","author":"Gralow","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.05.015_bib2","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1200\/JCO.2005.02.6187","article-title":"Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update","volume":"24","author":"Kaufmann","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.05.015_bib3","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/cncr.20298","article-title":"Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania","volume":"100","author":"Schwartz","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2019.05.015_bib4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1259\/bjr\/74430952","article-title":"Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy","volume":"84","author":"Shin","year":"2011","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clbc.2019.05.015_bib5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1245\/s10434-015-4918-0","article-title":"Can routine imaging after neoadjuvant chemotherapy in breast cancer predict pathologic complete response?","volume":"23","author":"Schaefgen","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2019.05.015_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.clbc.2016.12.010","article-title":"Role of magnetic resonance imaging in detection of pathologic complete remission in breast cancer patients treated with neoadjuvant chemotherapy: a meta-analysis","volume":"17","author":"Gu","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2019.05.015_bib7","doi-asserted-by":"crossref","first-page":"e88853","DOI":"10.1371\/journal.pone.0088853","article-title":"The role of mammographic calcification in the neoadjuvant therapy of breast cancer imaging evaluation","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2019.05.015_bib8","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1245\/s10434-016-5741-y","article-title":"Do calcifications seen on mammography after neoadjuvant chemotherapy for breast cancer always need to be excised?","volume":"24","author":"Feliciano","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2019.05.015_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2019.05.015_bib10","series-title":"The Guidelines for Mammography","year":"2010"},{"key":"10.1016\/j.clbc.2019.05.015_bib11","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.acra.2006.06.015","article-title":"Correlation of HER-2\/neu overexpression with mammography and age distribution in primary breast carcinomas","volume":"13","author":"Seo","year":"2006","journal-title":"Acad Radiol"},{"key":"10.1016\/j.clbc.2019.05.015_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s10278-008-9105-4","article-title":"Correlation of mammographic calcifications with HER-2\/neu overexpression in primary breast carcinomas","volume":"21","author":"Wang","year":"2008","journal-title":"J\u00a0Digit Imaging"},{"key":"10.1016\/j.clbc.2019.05.015_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/rpd\/ncu243","article-title":"HER2-positive breast cancer patients: correlation between mammographic and pathological findings","volume":"162","author":"Radenkovic","year":"2014","journal-title":"Radiat Prot Dosimetry"},{"key":"10.1016\/j.clbc.2019.05.015_bib14","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1245\/s10434-015-4993-2","article-title":"Residual mammographic microcalcifications and enhancing lesions on MRI after neoadjuvant systemic chemotherapy for locally advanced breast cancer: correlation with histopathologic residual tumor size","volume":"23","author":"Kim","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2019.05.015_bib15","first-page":"5375","article-title":"Identifying microcalcifications in benign and malignant breast lesions by probing differences in their chemical composition using Raman spectroscopy","volume":"62","author":"Haka","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2019.05.015_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10911-018-9396-0","article-title":"Radiological, histological and chemical analysis of breast microcalcifications: diagnostic value and biological significance","volume":"23","author":"Bonfiglio","year":"2018","journal-title":"J\u00a0Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.clbc.2019.05.015_bib17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/1471-2407-14-286","article-title":"Microcalcifications in breast cancer: an active phenomenon mediated by epithelial cells with mesenchymal characteristics","volume":"14","author":"Scimeca","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2019.05.015_bib18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bone.2013.01.013","article-title":"Microcalcifications in breast cancer: lessons from physiological mineralization","volume":"53","author":"Cox","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.clbc.2019.05.015_bib19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/bjc.2011.583","article-title":"Microcalcifications in breast cancer: novel insights into the molecular mechanism and functional consequence of mammary mineralisation","volume":"106","author":"Cox","year":"2012","journal-title":"Br J Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820919301247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820919301247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:19:05Z","timestamp":1761513545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820919301247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1526820919301247"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2019.05.015","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do Decreased Breast Microcalcifications After Neoadjuvant Chemotherapy Predict Pathologic Complete Response?","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2019.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}